Share on StockTwits

Equities researchers at Barclays boosted their price objective on shares of CME Group (NYSE:CME) from $75.00 to $77.00 in a research report issued on Monday. The firm currently has an “equal weight” rating on the stock. Barclays’ price objective would suggest a potential upside of 9.34% from the stock’s previous close.

Shares of CME Group (NYSE:CME) traded up 1.71% during mid-day trading on Monday, hitting $71.6263. The stock had a trading volume of 322,741 shares. CME Group has a 52 week low of $66.44 and a 52 week high of $84.71. The stock’s 50-day moving average is $70.79 and its 200-day moving average is $73.77. The company has a market cap of $24.052 billion and a price-to-earnings ratio of 23.47.

CME Group (NYSE:CME) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.83 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.83. The company had revenue of $777.00 million for the quarter, compared to the consensus estimate of $368.13 million. During the same quarter in the prior year, the company posted $0.73 earnings per share. The company’s quarterly revenue was up 8.1% on a year-over-year basis. Analysts expect that CME Group will post $3.32 EPS for the current fiscal year.

A number of other analysts have also recently weighed in on CME. Analysts at JPMorgan Chase & Co. reiterated a “hold” rating on shares of CME Group in a research note on Tuesday, June 10th. They now have a $67.50 price target on the stock, down previously from $69.50. Separately, analysts at Zacks downgraded shares of CME Group from a “neutral” rating to an “underperform” rating in a research note on Monday, June 9th. They now have a $63.00 price target on the stock. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of CME Group in a research note on Friday, May 9th. They now have a $84.00 price target on the stock, down previously from $89.00. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the company. CME Group presently has an average rating of “Hold” and a consensus target price of $75.95.

CME Group Inc (NYSE:CME) offer a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.